Clinical Trial Update: Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for patients with advanced pancreatic adenocarcinoma after gemcitabine failure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Pancreatic Adenocarcinoma Advanced or Metastatic | Phase 2 | Status: COMPLETED